Matching slides 119,566
Current window 85,741-85,770
Pages 3,986
Rows per page 30
Component: Imageclear collectionreset all

Component

85,741-85,770 of 119,566

filter-aware
09
The slide uses a combination of a value proposition statement and a conceptual diagram showing how their services map to three core outcomes.Cano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations Beat · Complication1 hit
21
Cano Health | Investor Presentation Deck | 48 slidesCano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations 1 hit
28
This is a highly aggressive, adversarial slide likely used in a proxy fight or corporate governance dispute.Cano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations 1 hit
33
Cano Health | Investor Presentation Deck | 48 slidesCano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations 1 hit
36
This is a classic proxy fight closing slide.Cano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations Beat · Closing ask1 hit
37
Cano Health | Investor Presentation Deck | 48 slidesCano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations 1 hit
38
Includes a callout box explaining the 1Q23 consolidation strategy.Cano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations 1 hit
48
Cano Health | Investor Presentation Deck | 48 slidesCano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations 1 hit
01
Slide 1
Cano Health | Results Presentation Deck | 19 slidesCano Health | Results Presentation Deck | 19 slides · Cano Health
Conference presentation Investor relations 1 hit
02
Cano Health | Results Presentation Deck | 19 slidesCano Health | Results Presentation Deck | 19 slides · Cano Health
Conference presentation Investor relations 1 hit
05
Uses a standard 5-column pillar layout to summarize the company's value proposition.Cano Health | Results Presentation Deck | 19 slides · Cano Health
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
The slide highlights a strategic shift toward consolidation in 1Q23, particularly in Florida.Cano Health | Results Presentation Deck | 19 slides · Cano Health
Conference presentation Investor relations Beat · Market SizeLoop · Pareto Focus1 hit
11
Cano Health | Results Presentation Deck | 19 slidesCano Health | Results Presentation Deck | 19 slides · Cano Health
Conference presentation Investor relations Beat · Financials1 hit
19
Cano Health | Results Presentation Deck | 19 slidesCano Health | Results Presentation Deck | 19 slides · Cano Health
Conference presentation Investor relations 1 hit
01
Slide 1
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
03
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
05
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
06
Includes Kaplan-Meier survival curves and a comparative table of clinical outcomes.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · Problem StatementLoop · Cost Of Inaction1 hit
16
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
25
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
26
Includes a BioRender diagram illustrating the molecular pathway.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
27
Includes PET scan imagery and comparative bar/dot plots.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
28
Includes a schematic of the mutation, a bar chart of H3K27me3 levels, a Kaplan-Meier survival curve, and a dot plot showing treatment effect.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
29
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
34
Includes a visual representation of survival rates (1 out of 20).Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
35
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
36
The slide includes a visual comparison of tumor burden in mice models (Vehicle vs ONC201 vs ONC212).Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
38
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
39
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
41
Chimerix | Investor Presentation Deck | 41 slidesChimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit